BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19827871)

  • 1. Cervical cancer screening: patients understanding in major hospitals in Malaysia.
    Othman NH; Devi BC; Halimah Y
    Asian Pac J Cancer Prev; 2009; 10(4):569-74. PubMed ID: 19827871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytological history of 148 women presenting with invasive cervical cancer].
    Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
    Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 5. Knowledge and barriers towards cervical cancer screening among young women in Malaysia.
    Al-Naggar RA; Low WY; Isa ZM
    Asian Pac J Cancer Prev; 2010; 11(4):867-73. PubMed ID: 21133593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors related to poor practice of Pap smear screening among secondary school teachers in Malaysia.
    Abdullah F; Aziz NA; Su TT
    Asian Pac J Cancer Prev; 2011; 12(5):1347-52. PubMed ID: 21875295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
    J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The screening histories of women with invasive cervical cancer, Connecticut.
    Janerich DT; Hadjimichael O; Schwartz PE; Lowell DM; Meigs JW; Merino MJ; Flannery JT; Polednak AP
    Am J Public Health; 1995 Jun; 85(6):791-4. PubMed ID: 7762711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does screening by "Pap" smears help prevent cervical cancer? A case-control study.
    Clarke EA; Anderson TW
    Lancet; 1979 Jul; 2(8132):1-4. PubMed ID: 87887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.
    Chan YM; Ismail MZH; Khaw WF
    BMC Womens Health; 2023 Jul; 23(1):389. PubMed ID: 37491253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low uptake of Pap smear testing among medical clinic attendees in a tertiary care hospital in Sri Lanka.
    Shivanthan MC; Arunakiri K; Wickramasinghe SI; Sumanasekera RD; Jayasinghe S; Rajapakse S
    Int Health; 2014 Jun; 6(2):138-43. PubMed ID: 24737803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and adenocarcinoma of the cervix.
    Sasieni P; Castanon A; Cuzick J
    Int J Cancer; 2009 Aug; 125(3):525-9. PubMed ID: 19449379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
    Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
    Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cervical cancer risk-factors in women referred to Yazd-Iran hospitals from 2002 to 2009.
    Karimi Zarchi M; Akhavan A; Gholami H; Dehghani A; Naghshi M; Mohseni F
    Asian Pac J Cancer Prev; 2010; 11(2):537-8. PubMed ID: 20843147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening after 50: near extinction?
    Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.